S&P 500   5,251.47 (+0.06%)
DOW   39,776.66 (+0.04%)
QQQ   443.89 (-0.21%)
AAPL   171.13 (-1.26%)
MSFT   420.22 (-0.29%)
META   488.40 (-1.11%)
GOOGL   150.71 (-0.11%)
AMZN   180.36 (+0.29%)
TSLA   177.22 (-1.45%)
NVDA   906.97 (+0.50%)
NIO   4.54 (-2.78%)
AMD   180.82 (+0.68%)
BABA   72.46 (+1.22%)
T   17.65 (+0.57%)
F   13.22 (+1.23%)
MU   117.91 (-1.03%)
CGC   9.07 (-5.03%)
GE   174.74 (-2.99%)
DIS   122.72 (+1.44%)
AMC   3.69 (-14.98%)
PFE   28.08 (+1.08%)
PYPL   67.24 (+1.01%)
XOM   115.87 (+0.78%)
S&P 500   5,251.47 (+0.06%)
DOW   39,776.66 (+0.04%)
QQQ   443.89 (-0.21%)
AAPL   171.13 (-1.26%)
MSFT   420.22 (-0.29%)
META   488.40 (-1.11%)
GOOGL   150.71 (-0.11%)
AMZN   180.36 (+0.29%)
TSLA   177.22 (-1.45%)
NVDA   906.97 (+0.50%)
NIO   4.54 (-2.78%)
AMD   180.82 (+0.68%)
BABA   72.46 (+1.22%)
T   17.65 (+0.57%)
F   13.22 (+1.23%)
MU   117.91 (-1.03%)
CGC   9.07 (-5.03%)
GE   174.74 (-2.99%)
DIS   122.72 (+1.44%)
AMC   3.69 (-14.98%)
PFE   28.08 (+1.08%)
PYPL   67.24 (+1.01%)
XOM   115.87 (+0.78%)
S&P 500   5,251.47 (+0.06%)
DOW   39,776.66 (+0.04%)
QQQ   443.89 (-0.21%)
AAPL   171.13 (-1.26%)
MSFT   420.22 (-0.29%)
META   488.40 (-1.11%)
GOOGL   150.71 (-0.11%)
AMZN   180.36 (+0.29%)
TSLA   177.22 (-1.45%)
NVDA   906.97 (+0.50%)
NIO   4.54 (-2.78%)
AMD   180.82 (+0.68%)
BABA   72.46 (+1.22%)
T   17.65 (+0.57%)
F   13.22 (+1.23%)
MU   117.91 (-1.03%)
CGC   9.07 (-5.03%)
GE   174.74 (-2.99%)
DIS   122.72 (+1.44%)
AMC   3.69 (-14.98%)
PFE   28.08 (+1.08%)
PYPL   67.24 (+1.01%)
XOM   115.87 (+0.78%)
S&P 500   5,251.47 (+0.06%)
DOW   39,776.66 (+0.04%)
QQQ   443.89 (-0.21%)
AAPL   171.13 (-1.26%)
MSFT   420.22 (-0.29%)
META   488.40 (-1.11%)
GOOGL   150.71 (-0.11%)
AMZN   180.36 (+0.29%)
TSLA   177.22 (-1.45%)
NVDA   906.97 (+0.50%)
NIO   4.54 (-2.78%)
AMD   180.82 (+0.68%)
BABA   72.46 (+1.22%)
T   17.65 (+0.57%)
F   13.22 (+1.23%)
MU   117.91 (-1.03%)
CGC   9.07 (-5.03%)
GE   174.74 (-2.99%)
DIS   122.72 (+1.44%)
AMC   3.69 (-14.98%)
PFE   28.08 (+1.08%)
PYPL   67.24 (+1.01%)
XOM   115.87 (+0.78%)
NYSE:OSCR

Oscar Health (OSCR) Stock Price, News & Analysis

$14.73
+0.52 (+3.66%)
(As of 01:40 PM ET)
Today's Range
$13.97
$14.90
50-Day Range
$10.73
$18.27
52-Week Range
$4.72
$18.55
Volume
1.25 million shs
Average Volume
3.36 million shs
Market Capitalization
$3.38 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.50

Oscar Health MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
8.8% Downside
$13.50 Price Target
Short Interest
Healthy
4.35% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.40mentions of Oscar Health in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.23) to $0.42 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.83 out of 5 stars

Finance Sector

777th out of 858 stocks

Hospital & Medical Service Plans Industry

11th out of 11 stocks

OSCR stock logo

About Oscar Health Stock (NYSE:OSCR)

Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

OSCR Stock Price History

OSCR Stock News Headlines

Raymond James Initiates Coverage on Oscar Health (NYSE:OSCR)
Only a fool would buy Nvidia today…
Average people are too busy throwing their money into Nvidia, Google, and every other overvalued tech firm… while missing what could be the biggest story of the decade.
OSCR Apr 2024 16.000 call
OSCR Apr 2024 10.000 put
OSCR Apr 2024 22.500 call
Oscars 2024: All the winners from the Academy Awards
Only a fool would buy Nvidia today…
Average people are too busy throwing their money into Nvidia, Google, and every other overvalued tech firm… while missing what could be the biggest story of the decade.
Oscar Health (OSCR) Appreciated 270% in 2023
OSCR Dec 2025 10.000 call
OSCR Mar 2024 25.000 call
OSCR Dec 2024 7.500 call
Oscar Health Inc (OSCR)
OSCR Oct 2024 7.500 call
OSCR Aug 2024 10.000 put
OSCR Oct 2024 5.000 put
Oscar Health stock jumps on first year of profitability
See More Headlines
Receive OSCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oscar Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/07/2024
Today
3/28/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Hospital & medical service plans
Sub-Industry
N/A
Fax
N/A
Employees
2,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.50
High Stock Price Target
$20.00
Low Stock Price Target
$7.50
Potential Upside/Downside
-5.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Net Income
$-270,730,000.00
Pretax Margin
-4.56%

Debt

Sales & Book Value

Annual Sales
$5.86 billion
Book Value
$3.51 per share

Miscellaneous

Free Float
171,055,000
Market Cap
$3.27 billion
Optionable
Optionable
Beta
1.82
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

OSCR Stock Analysis - Frequently Asked Questions

Should I buy or sell Oscar Health stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oscar Health in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" OSCR shares.
View OSCR analyst ratings
or view top-rated stocks.

What is Oscar Health's stock price target for 2024?

6 analysts have issued 1-year target prices for Oscar Health's stock. Their OSCR share price targets range from $7.50 to $20.00. On average, they predict the company's share price to reach $13.50 in the next year. This suggests that the stock has a possible downside of 8.8%.
View analysts price targets for OSCR
or view top-rated stocks among Wall Street analysts.

How have OSCR shares performed in 2024?

Oscar Health's stock was trading at $9.15 at the start of the year. Since then, OSCR stock has increased by 61.7% and is now trading at $14.80.
View the best growth stocks for 2024 here
.

Are investors shorting Oscar Health?

Oscar Health saw a decrease in short interest in the month of February. As of February 15th, there was short interest totaling 5,260,000 shares, a decrease of 16.9% from the January 31st total of 6,330,000 shares. Based on an average trading volume of 2,950,000 shares, the short-interest ratio is currently 1.8 days. Currently, 3.6% of the shares of the company are sold short.
View Oscar Health's Short Interest
.

When is Oscar Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our OSCR earnings forecast
.

How were Oscar Health's earnings last quarter?

Oscar Health, Inc. (NYSE:OSCR) announced its quarterly earnings results on Wednesday, February, 7th. The company reported ($0.66) EPS for the quarter, topping analysts' consensus estimates of ($0.74) by $0.08. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.43 billion. Oscar Health had a negative net margin of 4.62% and a negative trailing twelve-month return on equity of 29.99%. The business's revenue was up 43.9% compared to the same quarter last year. During the same period in the previous year, the company earned ($1.05) earnings per share.

What ETFs hold Oscar Health's stock?

ETFs with the largest weight of Oscar Health (NYSE:OSCR) stock in their portfolio include Invesco Dorsey Wright Healthcare Momentum ETF (PTH), SoFi Be Your Own Boss ETF (BYOB), SoFi Be Your Own Boss ETF (GIGE).iShares U.S. Insurance ETF (IAK) and

What guidance has Oscar Health issued on next quarter's earnings?

Oscar Health updated its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $8.3 billion-$8.4 billion, compared to the consensus revenue estimate of $6.8 billion.

What is Mario T. Schlosser's approval rating as Oscar Health's CEO?

207 employees have rated Oscar Health Chief Executive Officer Mario T. Schlosser on Glassdoor.com. Mario T. Schlosser has an approval rating of 95% among the company's employees. This puts Mario T. Schlosser in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 70.0% of employees surveyed would recommend working at Oscar Health to a friend.

When did Oscar Health IPO?

Oscar Health (OSCR) raised $1 billion in an initial public offering on Wednesday, March 3rd 2021. The company issued 31,000,000 shares at $32.00-$34.00 per share. Goldman Sachs, Morgan Stanley, Allen & Co., Wells Fargo Securities, BofA Securities and Credit Suisse acted as the underwriters for the IPO and Cowen, Lion Tree, Ramirez & Co. and Siebert Williams Shank were co-managers.

Who are Oscar Health's major shareholders?

Oscar Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (6.30%), Vanguard Group Inc. (6.20%), VK Services LLC (3.03%), Formation8 GP LLC (2.29%), Dimensional Fund Advisors LP (1.40%) and Gilder Gagnon Howe & Co. LLC (1.25%). Insiders that own company stock include Alessandrea C Quane, Alphabet Inc, Dennis Weaver, Joshua Kushner, Mario Schlosser, Meghan V Joyce, Ranmali Bopitiya, Richard Scott Blackley, Sid Sankaran, Thrive Partners Vii Growth Gp, and Victoria Baltrus.
View institutional ownership trends
.

How do I buy shares of Oscar Health?

Shares of OSCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:OSCR) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners